An evaluation of thyroid hormone status and oxidative stress in undialyzed chronic renal failure patients

Indian Journal of Physiology and Pharmacology

Volumn 50, Issue 3, 2006, Pages 279-284

  Singh, Pon Ajil ^a   Bobby, Zachariah ^a   Selvaraj, N ^a   Vinayagamoorthi, R ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chronic renal failure; Euthyroid sick syndrome; Lipid peroxidation; Thyroid profile; Total antioxidant status

Indexed keywords

ALBUMIN; ANTIOXIDANT; MALONALDEHYDE; THYROID HORMONE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; EUTHYROID SICK SYNDROMES; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SERUM ALBUMIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33747091992     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lazaras JM, Brenner BM. Chronic renal failure. In Fanci AS, Braunwald E, Issenlbacher KJ, editors. Harrison's principle of internal medicine. New York: McGraw Hill; 1998. p. 1513-1520.
2. Kalk WJ, Merely IE, Gold CH, Meyers. Thyroid function tests in patients on regular hemodialysis. Nephron 1980; 25: 173-178.
3. Ramirez G, O'Neill W Jr, Jubiz W, Bloomer HA. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Int Med 1976; 84: 672-725.
4. Jaossoo A, Murray IPC, Parkin J, Robertson MR, Jeremy D. Abnormalities in in vitro thyroid function tests in renal disease. Q J Med 1974; 43: 245-261.
5. Oddie TH, Flanigan WJ, Fisher DA. Iodine and thyroxine metabolism in anephric patients receiving chronic peritoneal dialysis. J Clin Endocr Metab 1970; 31: 277-282.
6. 3) in systemic illness. J Clin Endocr Metab 1975; 41: 1043-1049.
7. Czernichow P, Dauzet MC, Broyer M, Rappaport R. Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. J Clin Endocr Metab 1976; 43: 630-637.
8. Silverberg DS, Ulan RA, Fawcett DM, Dossetor JB, Grace MDA, Bettcher K. Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can Med Assoc J 1973; 189: 282.
9. Hershman JM, Krugman LG, Kopple JD, Reed AW, Azukizawa, Shinaberger JH. Thyroid function in patients undergoing maintance haemodialysis: unexplained low serum thyroxine concentration. Metabolism 1978; 27: 755-759.
10. Ramirez G, Jubiz W, Gutch CF, et al. Thyroid abnormalities in renal failure. A study 153 patients on chronic hemodialysis. Ann Intern Med 1973; 79: 500-504.
11. Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD. Thyroid function and metabolic state in chronic renal failure. Ann Int Med 1976; 85: 724.
12. Lim VS, Fang VS, Katz AI, Refetoff S. Thyroid dysfunction in chronic renal failure. J Clin Invest 1977; 60: 522-534.
13. Kaptein EM. Thyroid hormone metabolism and thyroid disease in chronic renal failure. Endocrin Rev 1996; 17: 45-63.
14. Brezezińska-Ślebodinska E. Fever induced oxidative stress: the effect on thyroid status and the 5′-monodeiodinase activity, protective role of selenium and vitamin E. J Physiol Pharm 2001; 52: 275-284.
15. Huang TS, Boado RJ, Chopra IJ, Solomon DH, Teco GNC. The effect of free radicals on hepatic 5′-monodeiodination of thyroxine and 3, 3′, 5′-triiodothyronine. Endocrinology 1987; 121: 498-503.
16. Van Bakel MME, Printzen G, Wermuth B, Wiesmann UN. Antixoidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 2000; 72: 976-981.
17. Goswami A, Rosenberg IN. Effects of glutathione on iodothyronine 5′-deiodinase activity. Endocrinology 1988; 123: 192-202.
18. Brezezińska-Ślebodinska E, Pietras B. The protective role of some antixodiants and scavengers on the free radicals-induced inhibition of the liver iodothyronine 5′-monodeiodinase activity and thiols content. J Physiol Pharmacol 1997; 48: 451-459.
19. Selvaraj N, Bobby Z, Das AK, Ramesh R, Koner BC. An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chim Acta 2002; 324: 45-50.
20. Selvaraj N, Bobby Z, Koner BC, Das AK. Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: A hypothesis on the role of lipid peroxides. Clin Chim Acta 2005; 360: 108-113.
21. Annuk MDA, Fellstrom B, Akerblom O, Zilmar K, Vilhalemn T, Zilmer M. Oxidative stress markers in pre-uremic patients. Clin Nephrol 2001; 56: 308-314.
22. Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevie Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 1999; 51: 233-241.
23. Zwolinska D, Gizeszczak W, Kilis-Pstrusinska K, Szprynger K, Szczepanska M. lipid peroxidation and antioxidant enzymes in children with chronic renal failure. J Trace Elem Med Biol 2004; 17: 291-299.
24. Yagi K. Lipid peroxides and related radicals in clinical medicine. Adv Exp Med Biol 1994; 366: 1-15.
25. Parola MDA, Bellomo G, Robino G, Barrera G, Dianzani MU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antiox Redox Signal 1999; 1: 255-284.
26. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412-426.
27. Yagi K. Assay for blood plasma or serum lipid peroxides. Methods Enzymol 1984; 105: 28-31.
28. Benzi IFF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999; 299: 15-27.
29. Chopra IJ, Hershman JM, Pardridge WM, Nicoloff JT. Thyroid function in nonthyroid illness. Ann Intern Med 1983; 98: 949-957.
30. Kaptein EM, Quion-Verde H, Choolijian CJ, Tang WW, Friedman PE, Rodriquez HJ, Massry SG. The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67: 187-197.
31. Mandel SJ, Berry MJ, Kieffer JD, Harney JW, Warne RL, Larsen PR. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinases. J Clin Endocrinol Metab 1992; 75: 1133-1139.
32. Zachara BA, Salak A, Koterska D, Manitius J, Wasowwicz W. Selenium and glutathione peroxidase in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 2004; 17: 291-299.
33. Chopra IJ, Wu S-Y, Nakamura Y, Solomon DH. Monodeiodination of 3,5,3′-triiodothyronine and 3,3′-diiodothyronine in vitro. Endocrinology 1978; 102: 1099.
34. Dudani RA, Desai KB, Mehta MN, Mani LS, ACharya VN. Thyroid dysfunction in uremia. J Assoc Phys India 1981; 29: 1038-1040.
35. Erdogan C, Unlucerci Y, Turkemn A, Kuru A, Cetin O, Bakpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002; 322: 157-161.
36. Pagliacci MC, Pelicei G, Grigani F et al. Thyroid function tests in patients undergoing maintenance peritoneal dialysis. Nephron 1987; 46: 225-230.